Märkte
| Wertpapier | Kurs | % | Buy | Sell | Kursziel ▲ | Potential |
|---|---|---|---|---|---|---|
| Integragen |
0,54 €
14.08.24 |
- | 0 | 0 | - | - |
| Smith & Nephew plc |
13,79 €
15.08.24 |
1,32 % | 1 | 0 | - | - |
| Pluristem Therapeutics Inc. |
0,97 €
26.07.22 |
-2,75 % | 0 | 0 | - | - |
| Misonix Inc. |
21,80 €
28.10.21 |
- | 0 | 0 | - | - |
| Biospecifics Techs |
73,00 €
02.12.20 |
-0,68 % | 0 | 0 | - | - |
| Civitas Solutions |
-
- |
- | 0 | 0 | - | - |
| Shl Telemedicine Ltd |
14,70 €
30.09.21 |
5,76 % | 0 | 0 | - | - |
| Genfit S.A. |
3,82 €
14.08.24 |
0,26 % | 0 | 0 | - | - |
| Accelerate Diagnostics Inc. |
1,51 €
14.08.24 |
-3,82 % | 1 | 1 | - | - |
| Harmonicare Medical Holdings Ltd |
-
- |
- | 0 | 0 | - | - |
| Advanced Medical Solutions Group plc |
2,80 €
14.08.24 |
-0,71 % | 0 | 0 | - | - |
| Hanger Orthopedic |
18,80 €
03.10.22 |
- | 0 | 0 | - | - |
| Cannabis Science Inc. |
0,011 €
22.11.19 |
- | 0 | 0 | - | - |
| Magellan Health Services |
83,50 €
03.01.22 |
- | 0 | 0 | - | - |
| Avita Medical Ltd |
1,72 €
13.08.24 |
-1,71 % | 0 | 0 | - | - |
| Tyme Technologies |
0,33 €
24.12.22 |
- | 0 | 0 | - | - |
| Aimmune Therapeutics Inc |
29,20 €
19.12.20 |
- | 0 | 0 | - | - |
| First Data Corp |
26,21 €
29.07.19 |
1,81 % | 0 | 0 | - | - |
| Horizon Discovery Group plc |
2,06 €
22.12.20 |
1,98 % | 0 | 0 | - | - |
| Immuron |
2,14 €
14.08.24 |
-0,93 % | 0 | 1 | - | - |
| Ravenquest Biomed Inc. |
0,006 €
21.08.21 |
- | 0 | 0 | - | - |
| Genfit SA |
3,54 €
14.08.24 |
-1,12 % | 0 | 0 | - | - |
| Novacyt S.A. |
0,79 €
15.08.24 |
16,88 % | 0 | 0 | - | - |
| Myokardia Inc |
191,00 €
30.01.21 |
- | 0 | 0 | - | - |
| Elexxion AG |
0,41 €
14.08.24 |
107,00 % | 0 | 0 | - | - |
| Medx Health Corp. |
0,079 €
18.08.21 |
- | 0 | 0 | - | - |
| PhaseBio Pharmaceuticals Inc |
0,068 €
24.02.23 |
- | 0 | 0 | - | - |
| Utah Medical Products Inc |
60,50 €
14.08.24 |
-0,82 % | 0 | 0 | - | - |
| Lifepoint Hospitals |
-
- |
- | 0 | 0 | - | - |
| Haemato AG Inh.-Wand.gen.s.1 2005/unbegr. |
3,78 €
25.07.19 |
-3,32 % | 0 | 0 | - | - |